HALOZYME REPORTS THIRD QUARTER 2024 FINANCIAL AND OPERATING RESULTS
Go back to HALOZYME REPORTS THIRD QUARTER 2024 FINANCIAL AND OPERATING RESULTS| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 113.90 -1.32 (1.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $115.22 | 52 Week High | $18.39 | |||
| Open | $115.36 | 52 Week Low | $6.96 | |||
| Day High | $115.63 | P/E | N/A | |||
| Day Low | $113.43 | EPS | $-0.58 | |||
| Volume | 1,958,300 | |||||
